University of Iowa News Release
May 8, 2006
Biotechnology Financing Focus of Entrepreneurial Ventures Group Event May 11
Financing of biotechnology ventures during the clinical trial phase will be the focus of a presentation at the next University of Iowa Entrepreneurial Ventures Group (EVG) event.
The lecture, hosted by the UI John Pappajohn Entrepreneurial Center (JPEC) and Iowa State Bank & Trust Company, will be held from 4 p.m. to 5:30 p.m. on May 11 in Room 2117 of the UI Medical Education and Research Facility (MERF). Dr. Charles Link, president and CEO of NewLink Genetics Corp., will discuss mitigating risk, validating market need and raising capital for biotechnology companies.
NewLink Genetics, located in Ames, Iowa, is a biopharmaceutical company applying innovative techniques in cancer biology to produce new diagnostic and therapeutic agents to improve the lives of cancer patients.
Jonathan Gilbert, faculty entrepreneurship coordinator at JPEC, says Link will discuss why biomedical discoveries require millions of dollars to successfully navigate clinical trials en route to FDA approval, requiring government grants and venture capital for financing.
"Dr. Link's company is one of the few in Iowa that has managed to raise money for clinical trials, remain in Iowa, leverage human resources locally and achieve the necessary milestones for continued external interest and funding," Gilbert said.
Link is also director of the Iowa Cancer Research Foundation and serves as the chief executive officer of BioProtection Systems Corporation. He is a recognized world leader in the development of new molecular therapeutics. He is board certified in both internal medicine and medical oncology and is a partner in Medical Oncology and Hematology Associates, a physician practice group located in Des Moines, Iowa. He holds a faculty appointment as a professor at Iowa State University and has a clinical appointment at the University of Iowa Carver College of Medicine. Dr. Link has received or is currently receiving grant or contract funding exceeding $3 million from several government agencies and private foundations.
The event is free and open to the public. Refreshments will be provided. Those interested in attending should RSVP to email@example.com or call 391-335-1022.
The event is part of the Entrepreneurial Ventures Group (EVG), a new initiative to promote faculty entrepreneurship and technology commercialization at the UI. EVG presentations are open to faculty, staff and community members interested in education, networking and supporting faculty entrepreneurship and technology commercialization activities. This interdisciplinary partnership includes the Henry B. Tippie College of Business, Roy J. and Lucille A. Carver College of Medicine, College of Engineering, College of Law, University of Iowa Research Foundation, and Office of the Vice President of for Research.
EVG programs are part of Iowa Centers for Enterprise: Business & Commercialization Services, which integrates existing economic development activities at UI. Iowa Centers for Enterprise offer a comprehensive program that promotes economic development and technology transfer, provides assistance to Iowa start-ups and existing Iowa businesses and communities, and helps the state of Iowa develop a creative, entrepreneurial workforce. It also optimizes the flow of University intellectual property into opportunities for licensing, commercialization and business development.
STORY SOURCE: University of Iowa News Services, 300 Plaza Centre One, Suite 371, Iowa City, Iowa 52242-2500.
CONTACTS: Media: George McCrory, 319-384-0012, firstname.lastname@example.org
ADDITIONAL INFORMATION: http://www.newlinkgenetics.com